We are live on
!
Find out more
IC
Inverness Counsel Portfolio holdings
AUM
$1.8B
1-Year Est. Return
9.9%
This Fund
S&P 500
This Quarter
Est. Return
+0.36%
1 Year Est. Return
-9.9%
3 Year Est. Return
+53.95%
5 Year Est. Return
+113.88%
10 Year Est. Return
–
AUM
$1.29B
AUM Growth
-$2.2M
(-0.17%)
Cap. Flow
+$4.85M
Cap. Flow
% of AUM
0.38%
Top 10 Holdings %
Top 10 Hldgs %
42.86%
Holding
102
New
5
Increased
23
Reduced
41
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$24.6M |
| 2 |
Progressive
PGR
|
+$19.5M |
| 3 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
+$12.5M |
| 4 |
RTX Corp
RTX
|
+$10.1M |
| 5 |
Home Depot
HD
|
+$9.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$16M |
| 2 |
Moody's
MCO
|
+$13.5M |
| 3 |
Walt Disney
DIS
|
+$10.7M |
| 4 |
TJX Companies
TJX
|
+$9.63M |
| 5 |
AbbVie
ABBV
|
+$8.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Industrials | 17.6% |
| 3 | Healthcare | 13.74% |
| 4 | Communication Services | 10.58% |
| 5 | Financials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAVM
26
DELISTED
Cavium, Inc.
CAVM
| $22.6M | 1.76% |
585,580
-11,580
| -2% | -$573K |
|
27
Verizon
VZ
$201B
| $21.9M | 1.7% |
391,738
-1,072
| -0.3% | -$55.6K |
|
28
Merck
MRK
$335B
| $21.8M | 1.69% |
396,099
-46,537
| -11% | -$2.48M |
|
29
SLB Ltd
SLB
$79.8B
| $21M | 1.63% |
265,922
+37,138
| +16% | +$2.85M |
|
30
McDonald's
MCD
$193B
| $21M | 1.63% |
174,686
+10,988
| +7% | +$1.38M |
|
31
ServiceNow
NOW
$128B
| $17.1M | 1.33% |
1,287,755
-98,450
| -7% | -$1.37M |
|
32
Xcel Energy
XEL
$49.5B
| $17M | 1.32% |
380,640
-97,210
| -20% | -$4.02M |
|
33
Edwards Lifesciences
EW
$52.8B
| $16.6M | 1.29% |
498,060
+58,275
| +13% | +$1.99M |
|
|
34
TJX Companies
TJX
$168B
| $14.6M | 1.14% |
378,662
-252,332
| -40% | -$9.63M |
|
|
35
AbbVie
ABBV
$441B
| $14.1M | 1.1% |
227,910
-145,619
| -39% | -$8.87M |
|
|
RDS.B
36
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $13.6M | 1.06% |
+242,845
| New | +$12.5M |
|
37
Bank of America
BAC
$451B
| $12.5M | 0.97% |
940,412
-526,795
| -36% | -$7.4M |
|
|
38
RTX Corp
RTX
$301B
| $11.5M | 0.89% |
177,779
+157,640
| +783% | +$10.1M |
|
|
39
Gilead Sciences
GILD
$172B
| $10.7M | 0.83% |
128,698
-180,330
| -58% | -$16M |
|
|
TWX
40
DELISTED
Time Warner Inc
TWX
| $9.68M | 0.75% |
131,599
+85,685
| +187% | +$6.34M |
|
41
Chevron
CVX
$392B
| $8.82M | 0.69% |
84,110
-42,715
| -34% | -$4.3M |
|
42
Church & Dwight Co
CHD
$24B
| $8.8M | 0.68% |
171,050
+55,780
| +48% | +$2.69M |
|
43
Johnson & Johnson
JNJ
$627B
| $6.58M | 0.51% |
54,252
+2,004
| +4% | +$228K |
|
44
Alphabet (Google) Class C
GOOG
$4.2T
| $6.25M | 0.49% |
180,620
-400
| -0.2% | -$14.4K |
|
45
Automatic Data Processing
ADP
$108B
| $6.23M | 0.48% |
67,846
| – | – |
|
46
EOG Resources
EOG
$74.8B
| $5.74M | 0.45% |
68,791
+60,046
| +687% | +$4.81M |
|
47
PepsiCo
PEP
$192B
| $5.5M | 0.43% |
51,866
-4,489
| -8% | -$463K |
|
48
Coca-Cola
KO
$377B
| $5.27M | 0.41% |
116,313
-600
| -0.5% | -$27.1K |
|
49
Knowles
KN
$3.29B
| $5.03M | 0.39% |
367,801
-250
| -0.1% | -$3.44K |
|
50
Enterprise Products Partners
EPD
$84B
| $4.1M | 0.32% |
140,240
-8,520
| -6% | -$229K |
|
Similar funds
SCA
ACM
RHBC
BDF
DY
WFA
CA
RIG
Inverness Counsel's Q2 2016 Portfolio in Review
As of Q2 2016, Inverness Counsel held 102 positions worth $1.29B, down 0.17% from $1.29B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Inverness Counsel's Q2 2016 filing shows 5 new, 23 increased, 41 reduced and 6 closed positions. Its largest new stake was Celgene Corp: 237,842 shares worth $23.5M. The largest sale was Gilead Sciences, an estimated $16M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Industrials and Healthcare.
- Inverness Counsel's largest Q2 2016 buy was Celgene Corp: 237,842 shares worth $23.5M.
- Inverness Counsel added most to Progressive in Q2 2016, an estimated $19.5M increase.
- Inverness Counsel's biggest Q2 2016 reduction was Gilead Sciences, cutting an estimated $16M.
- Inverness Counsel fully exited Moody's in Q2 2016, selling an estimated $13.5M.
- Inverness Counsel's ten largest holdings make up 43% of its $1.29B portfolio in Q2 2016.
- Inverness Counsel opened 5 new positions and closed 6 in Q2 2016.
- Inverness Counsel's portfolio value fell 0.17% quarter-over-quarter to $1.29B.
Based on Inverness Counsel's 13F filing for Q2 2016, filed 4 Aug 2016.